Kouki focuses on healthcare and life sciences at M12.
He has over 20 years of experience researching, translating, and investing in biomedical sciences. He has led and co-led over $5 billion in transactions and investments, which have funded 19 immunology and oncology drug programs. Of these, two cancer therapies are approved in the U.S. and EU and 11 are currently in clinical trials.
Before joining M12, Kouki was a partner at Romulus Capital and Andreessen Horowitz. Prior to his career in venture capital, Kouki was a Blavatnik Fellow (healthcare EIR) at Harvard and ran the AI clinical data analytics company, Medal, as chief operating officer and chief financial officer. Medal was acquired by Ciox Health in 2020. Prior to Medal, Kouki spent eight years in the biopharmaceutical industry, holding R&D, strategy, finance, and business development positions at Genentech, Novartis, and Baxalta.
Kouki earned a Bachelor of Arts in molecular and cell biology from Cornell University, a Ph.D. in clinical biochemistry from the University of Cambridge (Wellcome Trust Fellow), and an MBA from Harvard Business School (Robert S. Kaplan Life Sciences Fellow). He is a board member of the Harvard Business School Healthcare Alumni Association, a member of the Alexandria Ventures Seed Capital advisory board, and a mentor for life sciences and digital health startups through Massachusetts Biotechnology Council (MassBio).